And taking a GLP-1 medication increases the amount of the hormone in your body
The STEP trial data in detail Understanding the clinical trial evidence gives you a realistic baseline for what to expect
adems, este efecto se realiza en funcin de la concentracin de glucosa existente en cada momento
Efpeglenatide Efpeglenatide is a novel, long-acting GLP-1 receptor agonist developed by Hanmi Pharmaceuticals (South Korea) utilizing the proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) technology platform
Companies in this space include mitochondrial uncouplers with enhanced safety profiles (Rivus, Continuum), GDF15 targeting drugs (Novo, Lilly, Janssen), anti- activin II receptor mAb (Versanis), mir-22 inhibition (Resalis Tx) and gut-brain axis modulators (Kallyope)
You may be a good candidate if: You meet BMI and/or metabolic criteria commonly used in medical weight management Youve already tried structured lifestyle changes and still struggle You are under the care of a primary physician Youre willing to have labs and regular follow-ups You understand these medications are medical tools, not cosmetic quick fixes You may not be a good candidate if you have a disordered eating history, are pregnant or breastfeeding, have specific endocrine or gastrointestinal diseases, or want a set it and forget it solution